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Abstract Bacillus subtilis strain RP24, isolated from
rhizoplane of field grown pigeon pea, exhibited in vitro
antagonism against a wide range of phytopathogenic fungi.
An attempt was made to partially purify and characterize
the diffusible antifungal metabolite/s produced by the
strain RP24 and its negative mutant (NM) in potato dex-
trose medium. High performance liquid chromatography
(HPLC) of partially purified extract of RP24 showed the
presence of lipopeptide antibiotic iturin as a major peak
that was comparable to that of standard iturin A
(5.230 min) from Sigma–Aldrich whereas the correspond-
ing peak was absent in extract of NM. The structure was
further confirmed by liquid chromatographic mass spec-
trometric (LCMS) analysis as iturin A. LCMS analysis also
showed the presence of surfactin and fengycin besides
iturin A. Amplification of the lpa-14 (encodes the
40-phosphopantetheinyl transferase required for the matu-
ration of template enzyme of iturin A) and ituD (encodes a
putative malonyl coenzyme A transacylase, whose dis-
ruption results in a specific deficiency in iturin A produc-
tion) genes of iturin operon of strain RP24 was carried out
and the sequences obtained were compared with the
existing database of NCBI. The sequences of lpa-14 and
ituD gene of RP24 showed 98% and 97% homology with
lpa-14 and ituD genes of B. subtilis in the existing data-
base. The results indicated that strain RP24 harbors iturin
operon in its genome and a chemical mutation in this
operon might have resulted in loss of antifungal activity in
the negative mutant.
Introduction
With the intensification of agricultural production the
dependency on agrochemicals as means of crop protection
has also increased many folds over the past few decades.
But with the growing cost of the chemical pesticides and
increasing awareness about their negative effect the farm-
ers are looking for environmental and soil friendly substi-
tutes for these products to fulfill the consumers demand for
pesticide-free food while maintaining soil fertility and
environmental safety.
The use of microorganisms for biological purposes has
become an effective alternative to control plant pathogens.
There are many examples of formulations using bacteria or
fungal strains with biocontrol applications. Among them,
members of genus Bacillus are well-known antibiotic
producers [9, 12] which have advantage over other bio-
control microorganisms due to their inherent property to
form endospores and resistance to extreme conditions.
Bacillus species strains produce a broad spectrum of bio-
active peptides with great potential for biotechnological
and biopharmaceutical applications. A known class of such
compounds includes the lipopeptides surfactin, fengycin,
and iturin compounds which are amphiphilic membrane
active peptide antibiotics with potent antimicrobial activi-
ties and can be used as biopesticides for plant protection
[1, 5]. The peptide portions of these lipopeptides are
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produced nonribosomally with templates of the multi-
functional peptide synthetases [11, 21, 28]. The surfactin
and iturin compounds are cyclic lipoheptapeptides that
contain a b-hydroxy fatty acid and a b-amino fatty acid,
respectively, as lipophilic component. Fengycin is a lipo-
decapeptide with a b-hydroxy fatty acid in its side chain.
The lipopeptides belonging to the iturin family are potent
antifungal agents which can be used as biopesticides for
plant protection. McKeen et al. [12] obtained a heat
resistant antifungal compound obtained from B. subtilis
that was identified as a member of iturin group. Besson
et al. [4] identified the presence of antifungal antibiotics of
the iturin group in about 30 B. subtilis strains.
Bacillus subtilis strain RP24 isolated from rhizosphere
of pigeonpea has a suppressive effect against several
phytopathogens and expected to be used as a potential
biocontrol agent and a promising plant growth promoting
rhizobacteria [13, 14]. The biocontrol activity of the RP24
can be attributed to diffusible antifungal metabolites [15].
In the present investigation an attempt was made for
partial purification and characterization of the antifungal
metabolite/s produced by the B. subtilis RP24 and
amplification of the genes responsible for the antifungal
trait. The information generated could be used for com-
mercial exploitation of the strain for biofungicide
production.
Materials and Methods
Iturin A
Iturin A standard was procured from Sigma–Aldrich. The
solvents used were laboratory grade and distilled prior to
use. All the chemicals and reagents were analytical grade.
For HPLC acetonitrile used was HPLC grade. Deionised
distilled water was obtained from a Milli Q, millipore
water purification system.
Microorganisms
The bacterial culture RP24 selected for this study was
isolated from rhizoplane of field grown pigeonpea plant
[14] and identified as Bacillus subtilis (unpublished data).
An antifungal negative mutant (NM) of the strain RP24
generated by chemical mutagenesis [15] was also used in
the present study. Bacterial cultures were stored frozen in
10% glycerol at -70C. Working cultures were maintained
on tryptone yeast extract (TY; tryptone 5.0 g/l, yeast
extract 3.0 g/l, CaCl2 0.66 g/l) agar slants at 4C. The
phytopathogenic fungal cultures (Table 1) were obtained
from Indian Type Culture Collection, Division of Plant
Pathology, Indian Agricultural Research Institute, India
and maintained (4C) and multiplied (25 ± 1C) on potato
dextrose agar (PDA) medium.
Antifungal Activity of the Whole Culture of Bacillus
subtilis RP24
Bacterial culture grown in TY broth to a concentration of
ca 108 cfu/ml was streaked on PDA plate (3 cm away from
the center). Simultaneously a 5 mm diameter agar plug
containing actively growing fungal pathogen was placed in
the center of the plate (dual culture method). All the
pathogens (Table 1) were tested in triplicates. The plates
were incubated at 28 ± 1C for 7 days and the inhibitory
effect of the bacterial strain on fungal growth was evalu-
ated and expressed in terms of inhibition zone.
Extraction and Partial Purification of Antifungal
Metabolite/s
For production of antifungal metabolites the organism was
grown aerobically on potato dextrose broth maintained at
pH 7.0. The culture was grown at 30 ± 1C for 48, 96, and
144 h in 750 ml Erlenmeyer flasks containing 250 ml of
medium with shaking at 200 rpm in a shaker incubator.
After incubation bacterial cells were removed by centri-
fugation (8,0009g for 25 min) and the supernatant was
passed through 0.45 lm nitrocellulose membrane filter.
The pH of the filtered sterilized supernatant was adjusted to
2.0 by adding 6 N HCl. The acid precipitates were recov-
ered by centrifugation (10,000 rpm for 15 min at 4C) and
were extracted with methanol. The methanol extract
(100 ll) was bioassayed against the test pathogen M.
phaseolina by well diffusion method. Quantification of the
crude extract was done by drying the methanol extract
under vacuum and weighing the remaining light brown
Table 1 In vitro antagonism of phytopathogenic fungi by B. subtilis
RP24
Fungus Inhibition zone (mm)a
Macrophomina phaseolina 9.00 ± 0.82
Pythium ultimum 7.50 ± 0.72
P. aphanidermatum 8.25 ± 0.90
Rhizoctonia solani 8.80 ± 0.78
Fusarium solani 7.85 ± 0.83
F. oxysporum 8.25 ± 0.75
F. moniliforme 7.50 ± 0.71
F. udum 8.50 ± 0.83
Alternaria solani 7.25 ± 0.71
A. alternata 8.30 ± 0.84
Aspergillus niger 8.50 ± 0.76
a Values are the mean of triplicates
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residue. For further purification the crude fraction was
extracted with different non-polar and polar solvents and
all the fractions were bioassayed against the test fungus.
The active fraction was dissolved in methanol and used for
HPLC studies. The NM strain was also subjected to
extraction and partial purification in a similar way for a
comparative analysis.
High Performance Liquid Chromatographic (HPLC)
Analysis
Partially purified extract was analyzed by high perfor-
mance liquid chromatography (HPLC). A reverse phase
HPLC technique was used for quantitative analysis. A
Hewlett Packard HPLC instrument (series 1100) equipped
with degasser, quaternary pump, photo diode-array detector
connected with rheodyne injection system (20 ll loop) and
a computer (model Vectra) was used for analysis. The
stationary phase consisted of Lichrospher on C-18 packed
stainless steel column (250 mm 9 4 mm i.d). Chromato-
gram was recorded in a Windows’ NT based HP chem-
station programme. Acetonitrile: water (70:30) at 1 ml/min
flow rate was used as mobile phase. HPLC analysis was
performed at wavelength of 240 nm, which was detected
for absorption maxima using photodiode array. Twenty
microliters of sample and standard iturin were injected into
HPLC under standardized conditions. Each run was repe-
ated thrice and the detector response was measured in
terms of peak areas.
Liquid Chromatographic Mass Spectrometric (LCMS)
Analysis
LCMS of the partially purified fraction was done on Water
Alliance 2695 HPLC system with auto-sampler coupled
with a mass detector with positive and negative mode. The
mass spectrometer was operated in positive ionization
mode with selected ion recorder (SIR) acquisition. Mobile
phase was acetonitrile and 10 mM ammonium acetate
(60:40) at a flow rate of 0.3 ml/min. Major peaks were
produced by SIR of 10 channels in the TIC.
Amplification of Antifungal Genes
Genomic DNA preparation and electrophoretic analysis of
DNA in agarose gel were performed according to standard
protocols. Amplification of ituD and lpa-14 genes was car-
ried out by PCR with specific primers. Primers of ituD-f (50-
ATGAACAATCTTGCCTTTTTA-30) and ituD-r (50-TT
ATTTTAAAATCCGCAA TT-30) were used for amplifica-
tion of 1,203-bp ituD fragment corresponding to the B.
subtilis ituD gene (GenBank Accession No. AB050629),
whereas primers of lpa-14f (50-GAAAATTTACGGAGT
ATATATGGACCGC-30) and lpa-14r (50-TTATAACAG
CTCTTCATACGTTTTCATCTC-30) were employed for
the 675-bp lpa-14 gene (GenBank Accession No. D21876).
Amplification reaction was accomplished with a DNA
thermal cycler (peqlab Primus 96 advanced) using the step-
cycle program set for denaturing at 94C for 1 min,
annealing at 50C for 1 min, and extension at 72C for
1.5 min, for a total of 30 cycles.
Results
The rhizobacterial strain Bacillus subtilis RP24 could
inhibit all the test pathogens in dual culture test (Table 1)
due to the production of diffusible antifungal metabolites.
Based on the size of inhibition zones, M. phaseolina was
selected for further bioassay studies.
Production of extracellular antifungal metabolite/s by
the parent strain was studied under shaking conditions in
PDB at 30C. After incubation for 48, 96, and 144 h the
antifungal metabolites were extracted by acid precipitation.
After 48 h incubation 120 mg/l of the crude extract was
produced which increased by more than fourfolds by 96 h
(620 mg/l). Further incubation up to 144 h did not show
any significant increase in the concentration of the crude
extract indicating that 96 h incubation is sufficient for
maximum recovery of the metabolite/s. The observation
was further supported by size of inhibition zone produced
by crude extract of the culture broth incubated for 48, 96,
and 144 h. The crude extract was partially purified by
partitioning with different non-polar and polar organic
solvents (data not shown). The active fraction (205 mg/l)
was dissolved in methanol and used for further analysis.
The methanol extracts of the culture broth of the B.
subtilis RP24 and its NM were analyzed by HPLC as
described in the ‘‘Materials and Methods’’ section. In
comparison to negative mutant, methanolic extract of the
B. subtilis showed three extra peaks at retention time 5.236,
6.118, and 7.163 min (Fig. 1). When compared with iturin
A standard, the peak at 5.236 min having the same elution
profile as commercial iturin A, and was regarded as a
positive result for iturin A production. HPLC analysis
confirmed the production of iturin A by the parent strain
whereas the peak corresponding to iturin A was absent in
the methanol extract of culture broth of NM strain. The
presence of iturin A was further confirmed by co-injecting
the iturin A standard with extracted sample where
enhancement in the area of peak at 5.236 min was
observed. The results indicated that mutagenesis with EMS
might have altered the structure of the gene/s responsible
for the production of iturin A in the NM resulting in the
loss of antagonistic trait in the strain.
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The partially purified extract of the culture broth of the
B. subtilis RP24 was also analyzed by LCMS. Although
HPLC comparison by standard iturin A indicated the
presence of iturin A in the extract but the authenticity of
the produced iturin A was further established by LCMS
analysis. The other two peaks (6.118 and 7.163 min),
which were found to be absent in negative mutant strain
were also analyzed by LCMS. Mass spectrum of sample
showed three well-resolved groups of peaks at m/z values
between 967 and 1,073, between 1,082 and 1,110, and
between 1,483 and 1,549 (Fig. 2). The groups of peaks
could be attributed to the isoform ensembles of surfactins,
iturins, and fengycins, which represent the well-known
biosurfactant families by B. subtilis strains. Mass numbers
of all the surfactin, iturin, and fengycin peaks obtained by
LCMS of partially purified extracts and tentatively identi-
fied on the basis of literature information [27] are given
in Table 2. Besides comparison with authentic sample of
iturin in HPLC, it is the 14 mass unit difference in peaks
that suggests the presence of an iturin, as this difference
Fig. 1 HPLC analysis of
partially purified extracts of
RP24 and NM
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is characteristic of the two fatty acids of 14 and 15 C-
atom that are called ituric acids and are associated with
iturin.
Amplification of ituD (*1,203 bp) (Fig. 3) and lpa-14
(*675 bp) (Fig. 4) genes of B. subtilis RP24 suggested that
the strain harbor the gene cluster required for iturin A bio-
synthesis. The PCR products were sequenced (Link Biotech,
India) and the sequences obtained were subjected to nucle-
otide BLAST analysis and submitted to NCBI GenBank.
Sequence of ituD gene of RP24 (GeneBank Accession No.
FJ494832) showed 97% homology with ituD gene of B.
subtilis (NCBI database, Accession No. EU263005). The
sequence of lpa-14 gene of RP24 (Accession No. EU797520)
showed 98% homology with lpa-14 gene of B. subtilis
(NCBI database, Accession No. D21876).
Discussion
Bacillus subtilis, the most common representative of the
genus, exhibits broad spectrum of action against different
plant pathogens due to its ability to produce a great
abundance of antibiotics with an amazing varieties of
structures [20]. These compounds include predominantly
peptides that are resistant to hydrolysis by proteinases
and proteases. Their activity is also resistant to high
Fig. 2 MS of partially purified
extract RP24
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temperature and a wide range of pH [19]. In our study, the
Bacillus subtilis strain RP24 exhibited in vitro antagonism
against a wide range of phytopathogenic fungi due to the
production of diffusible antifungal metabolites. An incu-
bation period of 96 h was found to be optimum for the
maximum production of antifungal metabolites by the
strain RP24 in PD broth at 30C. The antifungal metabo-
lite/s was thermostable, pH stable, proteinase K resistant,
soluble in methanol, ethanol, and acetic acid but insoluble
in water indicating toward lipopeptide nature of the
metabolite/s [15]. To clarify the involvement of antimi-
crobials in the biocontrol performance, additional evidence
may be offered by mutagenizing the strain to reduce
or avoid biocontrol activity. In the present study, an
antifungal negative mutant of B. subtilis RP24 created by
chemical mutagenesis [15] could not exhibit biocontrol
properties in vitro. The chromatographic analysis using
HPLC and LCMS showed the occurrence of three different
lipopeptide antibiotics, iturin A (as major) fraction and
fengycin and surfactin (as minor fractions) in the partially
purified extract of strain RP24 whereas none of these
compounds was detected in the corresponding extract of
negative mutant. Thus the production of three different
lipopeptide antibiotics could be related with the biocontrol
efficiency of RP24. The simultaneous excretion of different
lipopeptides is often observed in Bacillus spp. [18, 19].
Bacillus subtilis GA1 is a producer of a wide variety of
lipopeptides, iturin A, surfactin, and fengycin with various
lengths of the fatty acid chains from C14 to C18 [24].
Coproduction of iturin A, fengycin, and surfactin by B.
subtilis strains UMAF6614 and UMAF6639 was found
responsible for the biocontrol of cucurbit powdery mildew
Podosphaera fusca [17]. Mixture of surfactin and iturin
produced by B. subtilis RB14 and B. amyloliquefaciens
BNM 122 increased the antifungal activity since the former
compound is able to form mixed micelles with iturin and
thereby improves its activity [23]. Furthermore, surfactin
seem to help the organisms in biofilm formation thus
contributing to the protective activity by preventing the
growth of other microorganisms as shown in Arabidopsis
against Pseudomonas syringae [2]. Increasing the diversity
of antibiotics excreted by the organism to the soil might
result in an increase of the range of action on different
phytopathogens. The target site for lipopeptide antibiotics
is the fungal cytoplasmic membrane. Iturin antibiotics
Table 2 Assignment of all mass peaks produced by B. subtilis by
LCMS
Mass peaks (m/z) Probable assignment
1044.6 C14 surfactin [M ? Na]
?
1059.09 C15 surfactin [M ? Na]
?
1060.10 C14 surfactin [M ? K]
?
1073.25 C16 iturin [M ? H]
?
1082.35 C17 iturin [M ? H]
?
1095.52 C18 iturin [M ? H]
?
1110.79 C19 iturin [M ? H]
?
1467.03 C15 fengycin [M ? Na]
?
1483.35 C16 fengycin [M ? Na]
?
1497.8 C17 fengycin [M ? Na]
?
1513.9 C16 fengycin [M ? Na]
?
1529.42 C16 fengycin [M ? K]
?
The mass data represent the monoisotopic mass numbers
Fig. 3 Amplicon (*1,200 bp) of ituD gene of B. subtilis RP24
Fig. 4 Amplicon (*675 bp) of lpa-14 gene of B. subtilis RP24
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increase the membrane permeability of the target micro-
organism due to the formation of ion channels on the cell
membranes thereby increasing the permeability to K? that
is associated with fungicidal activity. Modification of
membrane permeability and lipid composition of S. cervi-
siae cells by iturin A has been reported [3, 10, 29].
In the present study, an attempt was also made to
amplify the lpa-14 and ituD genes of iturin operon. In
Bacillus Iturin operon is 38–40 kb in size and consists of
four open reading frames ituA, ituB, ItuC, and ituD [25].
The ituD encodes a putative malonyl coenzyme A trans-
acylase, whose disruption results in a specific deficiency in
iturin A production [8, 25]. The ituA (lpa-14) encodes the
40-phosphopantetheinyl transferase required for maturation
of template enzyme of iturin A [7]. Both these genes play
leading role in the production of iturin A. The PCR method
using specific primers could be applied to detect the pres-
ence of ituD and lpa-14 genes [6]. The lpa-14 and iduD
genes of RP24 showed 98% and 97% homology with the
corresponding genes of iturin operon of Bacillus subtilis in
the existing database, respectively. Bacillus subtilis 168
Marburg could not produce lipopeptide surfactin, fengycin,
and iturin due to a frameshift mutation in sfp gene coding
for 40-phosphopantetheinyl transferase which is responsible
for conversion of nascent antibiotic synthetases to their
active holoforms [16]. Interestingly introduction of a native
sfp gene into B. subtilis 168 provoked surfactin and
fengycin production [26]. In the present study, the NM
could not produce any of the antibiotics, as detected in
parent strain. This could be due to simultaneous mutations
in the operons of three antibiotics or due to the mutation in
some common gene/s that might be involved in the pro-
duction of all three antibiotics in B. subtilis RP24.
Iturin and fengycin are lipopeptide antibiotics with a
broad antifungal spectrum. Surfactin are strong biosurfac-
tants and have some synergistic effects on the antifungal
activity of iturin A. They have wide application in industries
and medicine [22]. In our present observation, an efficient
iturin A producing B. subtilis RP24 strain along with
fengycin and surfactin provide a broad antifungal spectrum
which can be further exploited as a biocontrol agent and for
the commercial production of antifungal compounds.
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